Understanding fibromyalgia and its related disorders

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 10, Issue 2, 2008, Pages 133-144

  Goldenberg, Don L ^a   Bradley, Laurence A ^b   Arnold, Lesley M ^c   Glass, Jennifer M ^d   Clauw, Daniel J ^d  

^a NEWTON WELLESLEY HOSPITAL   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CYCLOBENZAPRINE; DULOXETINE; FLUOXETINE; GABAPENTIN; MILNACIPRAN; PARACETAMOL; PAROXETINE; PRAMIPEXOLE; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ZOLPIDEM; ZOPICLONE;

AEROBIC EXERCISE; ANXIETY; ATTENTION; AUTONOMIC NEUROPATHY; BEDTIME DOSAGE; BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITION; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONFERENCE PAPER; CONSTIPATION; DIZZINESS; DROWSINESS; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; FATIGUE; FIBROMYALGIA; HEART PALPITATION; HEREDITY; HUMAN; INSOMNIA; LIBIDO; MEMORY; MONOTHERAPY; MORNING DOSAGE; NAUSEA; NEUROENDOCRINE DISEASE; NOCICEPTION; PAIN; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRURITUS; RECOMMENDED DRUG DOSE; SEDATION; SELF REPORT; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; TREATMENT PLANNING; WEIGHT GAIN; XEROSTOMIA;

EID: 45749087411     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/pcc.v10n0208     Document Type: Conference Paper

References (104)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-172
2. Lawrence RC, Felson DT, Helmick CG, et al. for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States, pt 2. Arthritis Rheum 2008;58:26-35
3. Arnold LM, Hudson JI, Keck PE, et al. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006;67:1219-1225
4. Garrison RL, Breeding PC. A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses 2003;61:182-189
5. Weir PT, Harlan GA, Nkoy FL, et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 2006;12:124-128
6. Hudson JI, Arnold LM, Keck PE, et al. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 2004;56:884-891
7. Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum 2004;50:944-952
8. Wolfe F, Russell IJ, Vipraio G, et al. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997;24:555-559
9. Cohen H, Buskila D, Neumann L, et al. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 2002;46:845-847
10. Offenbaecher M, Bondy B, de Jonge S, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999;42:2482-2488
11. Hoefgen B, Schulze TG, Ohlraun S, et al. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry 2005;57:247-251
12. Yeo A, Boyd P, Lumsden S, et al. Association between functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowl syndrome in women. Gut 2004;53:1452-1458
13. Camilleri M. Is there a SERT-ain association with IBS? Gut 2004;53:1396-1399
14. Al-Allaf AW, Dunbar KL, Hallum NS, et al. A case-control study examining the role of physical trauma in the onset of fibromyalgia syndrome. Rheumatology (Oxford) 2002;41:450-453
15. Harkness EF, Macfarlane GJ, Nahit E, et al. Mechanical injury and psychosocial factors in the work place predict the onset of widespread body pain. Arthritis Rheum 2004;50:1655-1664
16. Davis MC, Zautra AJ, Reich JW. Vulnerability to stress among women in chronic pain from fibromyalgia and osteoarthritis. Ann Behav Med 2001;23:215-226
17. McCain GA, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl 1989;19:154-157
18. Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary- adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994;37:1583-1592
19. Vaerøy H, Qiao ZG, Mørkrid L, et al. Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1998;16:1460-1465
20. Bou-Holaigah I, Calkins H, Flynn JA, et al. Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol 1997;15:239-246
21. Martínez-Lavín M, Hermosillo AG, Rosas M, et al. Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis. Arthritis Rheum 1998;41:1966-1971
22. Stein PK, Domitrovich PP, Ambrose K, et al. Sex effects on heart rate variability in fibromyalgia and gulf war illness. Arthritis Rheum 2004;51:700-708
23. Roizenblatt S, Moldofsky H, Benedito-Silva AA, et al. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001;44:222-230
24. Martínez-Lavín M, Hermosillo AG, Mendoza C, et al. Orthostatic sympathetic derangement in subjects with fibromyalgia. J Rheumatol 1997;24:714-718
25. Harding SM. Sleep in fibromyalgia patients: subjective and objective findings. Am J Med Sci 1998;315:367-376
26. Carli G, Suman AL, Biasi G, et al. Reactivity to superficial and deep stimuli in patients with chronic musculoskeletal pain. Pain 2002;100:259-269
27. Ledeboer A, Liu T, Shumilla JA, et al. The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain. Neuron Glia Biol 2007;2:279-291
28. Watkins LR, Milligan ED, Maier SF. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol 2003;521:1-21
29. Gracely RH, Petzke F, Wold JM, et al. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46:1333-1343
30. Wood PB, Patterson JC II, Sunderland JS, et al. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 2007;8:51-58
31. White KP, Nielson WR, Harth M, et al. Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 2002;29:588-594
32. MacFarlane GJ, Thomas E, Papageorgiou AC, et al. The natural history of chronic pain in the community: a better prognosis than in the clinic? J Rheumatol 1996;23:1617-1620
33. Mease PJ, Clauw DJ, Arnold LM, et al. Fibromyalgia syndrome. J Rheumatol 2005;32:2270-2277
34. Pope HG Jr, Hudson JI. A supplemental interview for forms of "affective spectrum disorder." Int J Psychiatry Med 1991;21:205-232
35. Sayar K, Aksu G, Ak I, et al. Venlafaxine treatment of fibromyalgia. Ann Pharmacother 2003;37:1561-1565
36. Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32:1975-1985
37. Arnold LM, Lu Y, Crofford LJ, et al, for the Duloxetine Fibromyalgia Trial Group. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974-2984
38. Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005;119:5-15
39. Fishbain D. Evidence-based data on pain relief with antidepressants. Ann Med 2000;32:305-316
40. Goldenberg D, Mayskiy M, Mossey C, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996;39:1852-1859
41. Mula M, Pini S, Gassano GB. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol 2007;27:263-272
42. Drewes AM, Andreasen A, Jennum P, et al. Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 1991;20:288-298
43. Moldofsky H, Lue FA, Mously C, et al. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol 1996;23:529-533
44. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics 2000;41:104-113
45. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-1273
46. Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007;56:1336-1344
47. Hindmarch I, Dawson J, Stanley N. A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep 2005;28:187-193
48. Foldvary-Schaefer N, De Leon Sanchez I, Karafa M, et al. Gabapentin increases slow-wave sleep in normal adults. Epilepsia 2002;43:1493-1497
49. Nicassio PM, Radojevic V, Weisman MH, et al. A comparison of behavioral and educational interventions for fibromyalgia. J Rheumatol 1997;24:2000-2007
50. Gloaguen V, Cottraux J, Cucherat M, et al. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord 1998;49:59-72
51. Gould RA, Otto MW, Pollack MP, et al. Cognitive-behavioral and pharmacological treatment of generalized anxiety disorder: a preliminary meta-analysis. Behav Ther 1997;28:285-305
52. Busch AJ, Barber KA, Overend TJ, et al. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev 2007;4:CD003786
53. Dunn AL, Trivedi MH, Kampert JB, et al. Exercise treatment for depression: efficacy and dose response. Am J Prev Med 2005;28:1-8
54. Arnold LM. Biology and therapy of fibromyalgia: new therapies in fibromyalgia. Arthritis Res Ther 2006;8:212
55. Zachrisson O, Regland B, Jahreskog M, et al. A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). J Psychosom Res 2002;52:501-509
56. Bennett RM, Jones J, Turk DC, et al. An internet survey of 2596 people with fibromyalgia. BMC Musculoskelet Disord 2007;9:27. doi: 10.1186/1471-2474-8- 27. Available at http://www.biomedcentral.com/1471-247/8/27. Accessed on Nov 2, 2007
57. Katz RS, Heard AR, Mills M, et al. The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia. J Clin Rheumatol 2004;10:53-58
58. Glass JM, Park DC, Minear M, et al. Memory beliefs and function in fibromyalgia patients. J Psychosom Res 2005;58:263-269
59. Glass JM, Park DC. Cognitive dysfunction in fibromyalgia. Curr Rheumatol Rep 2001;3:123-127
60. Dick B, Eccleston C, Crombez G. Attentional functioning in fibromyalgia, rheumatoid arthritis, and musculoskeletal pain patients. Arthritis Rheum 2002;47:639-644
61. Park DC, Glass JM, Minear M, et al. Cognitive function in fibromyalgia patients. Arthritis Rheum 2001;44:2125-2133
62. Glass JM, Park DC, Minear M. Memory performance with divided attention in fibromyalgia patients. Arthritis Rheum 2004;50(suppl 9):S489
63. Leavitt F, Katz RS. Distraction as a key determinant of impaired memory in patients with fibromyalgia. J Rheumatol 2006;33:127-132
64. Glass JM, Park DC, Crofford LJ, et al. Fibromyalgia patients show reduced executive/cognitive control in a task-switching test. Arthritis Rheum 2006;54 (suppl 9):S610
65. Suhr JA. Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. J Psychosom Res 2003;55:321-329
66. Landro NI, Stiles TC, Sletvold H. Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 1997;42:297-306
67. Banks S, Dinges DF. Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med 2007;3:519-528
68. Newcomer JW, Selke G, Melson AK, et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 1999;56:527-533
69. Starkman MN, Giordani B, Berent S, et al. Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosom Med 2001;63:985-993
70. Sephton SE, Studts JL, Hoover K, et al. Biological and psychological factors associated with memory function in fibromyalgia syndrome. Health Psychol 2003;22:592-597
71. Hart RP, Martelli MF, Zasler ND. Chronic pain and neuropsychological functioning. Neuropsychol Rev 2000;10:131-149
72. Glass J, Williams D, Gracely R, et al. Myofascial pain and fibromyalgia relationship of self-reported pain, tender point count, and evoked pressure pain sensitivity to cognitive function in fibromyalgia. J Pain 2004;5(suppl 1):S38
73. Maizels M, McCarberg B. Antidepressants and antiepileptic drugs for chronic noncancer pain. Am Fam Physician 2005;71:483-490
74. Dadabhoy D, Clauw DJ. Therapy insight: fibromyalgia-a different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol 2006;2:364-372
75. Flexeril (cyclobenzaprine) [package insert]. West Point, Pa: Merck; 2001 http://www.fda.gov/cder/foi/label/2003/017821s045lbl.pdf. Accessed on Dec 18, 2007
76. Vitton O, Gendreau M, Gendreau J, et al. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004;19(suppl 1):S27-S35
77. Russell I, Kamin M, Bennett RM, et al. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol 2000;6:250-257
78. Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 2003;30:1070-1074
79. Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 2005;52:2495-2505
80. Bennett RM, Kamin M, Karim R, et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 2003;114:537-545
81. Bennett RM, Schein J, Kosinski MR, et al. Impact of fibromyalgia pain on healthrelated quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum 2005;53:519-527
82. Arnold LM, Hess EV, Hudson JI, et al. A randomized, placebo-controlled, doubleblind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002;15:191-197
83. Patkar AA, Masand PS, Krulewicz S, et al. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med 2007;120:448-454
84. Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 1994;23:255-259
85. Cantini F, Bellandi F, Niccoli L, et al. Fluoxetine combined with cyclobenzaprine in the treatment of fibromyalgia. Minerva Med 1994;85:97-100
86. Anderberg UM, Marteinsdottir I, von Knorring L. Citalopram in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study. Eur J Pain 2000;4:27-35
87. Fleming MF, Balousek SL, Klessig CL, et al. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain 2007;8:573-582
88. Staud R. Treatment of fibromyalgia and its symptoms. Expert Opin Pharmacother 2007;8:1629-1642
89. Busch A, Schachter CL, Peloso PM, et al. Exercise for treating fibromyalgia syndrome. Chochrane Database Syst Rev 2002;3:CD003786
90. Haanen HC, Hoenderdos HT, van Romunde LK, et al. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 1991;18:72-75
91. White KP, Nielson WR, Harth M, et al. Does the label " fibromyalgia" alter health status, function, and health service utilization? a prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis Rheum 2002;47:260-265
92. Burckhardt CS, Mannerkorpi K, Hedenberg L, et al. A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 1994;21:714-720
93. Mannerkorpi K, Henriksson C. Nonpharmacological treatment of chronic widespread musculoskeletal pain. Best Pract Res Rheumatol 2007;21:513-534
94. Gowans SE, deHueck A, Voss A, et al. Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia. Arthritis Rheum 2001;45:519-529
95. Williams DA, Cary MA, Groner KH, et al. Improving physical function status in patients with fibromyalgia: a brief cognitive behavioral intervention. J Rheumatol 2002;29:1280-1286
96. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004;292:2388-2395
97. Duncan B, White A, Rahman A. Acupuncture in the treatment of fibromyalgia in tertiary care: a case series. Acupunct Med 2007;25:137-147
98. Staud R. Are tender point injections beneficial: the role of tonic nociception in fibromyalgia. Curr Pharm Des 2006;12:23-27
99. Hains G, Hains F. A combined ischemic compression and spinal manipulation in the treatment of fibromyalgia: a preliminary estimate of dose and efficacy. J Manipulative Physiol Ther 2000;23:225-230
100. Field T, Diego M, Cullen C, et al. Fibromyalgia pain and substance P decrease and sleep improves after massage therapy. J Clin Rheumatol 2002;8:72-76
101. Babu AS, Mathew E, Danda D, et al. Management of patients with fibromyalgia using biofeedback: a randomized control trial. Indian J Med Sci 2007;61:455-461
102. Taggart HM, Arslanian CL, Bae S, et al. Effects of T'ai Chi exercise on fibromyalgia symptoms and health-related quality of life. Orthop Nurs 2003;22:353-360
103. da Silva GD, Lorenzi-Filho G, Lage LV. Effects of yoga and the addition of Tui Na in patients with fibromyalgia. J Altern Complement Med 2007;13:1107-1114
104. Sarzi-Puttini P, Buskila D, Carrabba M, et al. Treatment strategy in fibromyalgia syndrome: where are we now? [published online ahead of print Oct 30, 2007]. Semin Arthritis Rheum 2007. doi: 10.1016/j.semarthrit.2007.08.008